Skip to main content
. 2009 Jan 17;32(1):133–137. doi: 10.1590/S1415-47572009005000008

Table 1.

Frequency of mutant spots observed in standard (ST) cross trans-heterozygote markers of D.melanogaster treated with doxorubicin (DXR) in the absence and presence of organic tomato extract (ORT).

Series 
Spots per fly (n. of spots); stat. diagnosesa
DXR (mg/mL) ORT (%) N. of flies Small single spots (1-2 cells)b Large single spots (> 2 cells)b Twin spots Total spots Spots with mwh clone c
0 0 40 0.45 (18) 0.13 (05) 0.05 (02) 0.63 (25) 23
0 25 40 0.30 (12) ns 0.13 (05) ns 0.05 (02) ns 0.48 (19) ns 19
0 50 40 0.48 (19) ns 0.05 (02) ns 0.05 (02) ns 0.58 (23) ns 23
0 100 40 0.45 (18) ns 0.10 (04) ns 0.03 (01) ns 0.58 (23) ns 23
0.125 0 40 2.40 (96) 1.73 (69) 1.43 (57) 5.55 (222) 200
0.125 25 40 2.78 (111) ns 2.00 (80) ns 1.63 (65) ns 6.40 (256) ns 243
0.125 50 40 4.40 (176)* 4.23 (169)* 3.05 (122)* 11.68 (467)* 418
0.125 100 40 5.10 (204)* 3.15 (126)* 3.00 (120)* 11.25 (450)* 425

aStatistical diagnoses according to Frei and Würgler (1995) with a two-tailed U-test. *p ≤ 0.05; ns, not significant.

bIncluding rare flr3 single spots.

cConsidering mwh clones from single and twin mwh spots.